This study highlighted the critical role of the gut microbiota in the pathogenesis of systemic autoinflammation and metabolic diseases by showing how the NLRP6 and NLRP3 inflammasomes negatively control the development of MASH and metabolic syndrome by altering them. This evidence concerns the gene NLRP3 and metabolic syndrome.